ThermoGenesis Holdings - aVenture Company Research
ThermoGenesis Holdings
ThermoGenesis Holdings, Inc., a California-based medical organization, develops and markets automated technologies for cell-based therapies, including CAR-T immunotherapy.
ThermoGenesis Holdings, Inc., based in Rancho Cordova, California, develops and markets automated technologies for cell-based therapies, including chimeric antigen receptor (CAR-T) immunotherapy. The company offers a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology. Notably, its semi-automated, functionally closed CAR-TXpress platform streamlines the manufacturing process for the emerging CAR-T immunotherapy market.
ThermoGenesis Holdings has made significant strides in the medical technology sector, particularly in advancing the automation of cell-based therapies. Its innovative CAR-TXpress platform has positioned the company as a key player in the immunotherapy space, enhancing the efficiency and scalability of CAR-T cell manufacturing. The company's impact is evident in its contributions to improving therapeutic outcomes and expanding access to cutting-edge treatments.